Life Sciences Exploratory biomarker discovery driven by ultra-sensitive assaysYao Chen of Sanofi shares how her team achieves sensitivity, specificity, precision, and robustness in protein biomarker detection
Drug Discovery & Development Beyond binding – iPSC-based functional safety screening for oncology modalities Jan 22, 2026
Drug Discovery & Development Beyond binding – iPSC-based functional safety screening for oncology modalities Jan 22, 2026
Drug Discovery & Development TechTalk: Fast, accurate, accessible quantification across diverse biologics Jan 23, 2026
Life Sciences University of California Irvine redefines mass spectrometry imaging with the Shimadzu iMScope QT
Drug Discovery & Development ELRIG announces Dr. Stephen Ward and Dr. Annarita Miccio as keynote speakers for Cell and Gene Therapy 2026
Drug Discovery & Development Nuclera extends Series C funding to $87M to advance antibody engineering